Trial Profile
A Randomized, Open-label, Single-dose, 2-treatment, 2-way, 2-period Crossover Study to Evaluate the Safety and the Pharmacokinetic Characteristics of DKF-313 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2021
Price :
$35
*
At a glance
- Drugs Dutasteride/tadalafil (Primary) ; Dutasteride; Tadalafil
- Indications Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Sponsors Dongkook Pharmaceutical
- 01 Jul 2021 Status changed from recruiting to completed.
- 11 Feb 2015 New trial record